2014 Analysis of Enteric Diseases in France: Market Outlook and Emerging Opportunities

Date: November 25, 2013
Pages: 322
Price:
US$ 2,200.00 US$ 1,760.00
License [?]:
Publisher: Venture Planning Group
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: 275E15DC688EN
Leaflet:

Download PDF Leaflet

2014 Analysis of Enteric Diseases in France: Market Outlook and Emerging Opportunities
About This Report

This new 322-page report from Venture Planning Group presents detailed analysis of the French Enteric Diseases market, including sales forecasts and supplier shares for Campylobacter, Cryptosporidium, E. Coli, Enterovirus, Rhinovirus, Rotavirus, Salmonella, Shigella, Vibrio and Yersinia.

The report provides test volume and sales projections for Hospitals and Commercial/Private Labs.

In addition to market share and sales forecasts, the report:
  • Examines market applications of Molecular Diagnostics, Monoclonal Antibodies, Immunoassays, IT and other emerging technologies;
  • Reviews features and operating characteristics of major analyzers used For microbiology testing;
  • Profiles key suppliers and potential market entrants developing innovative technologies and products; and
  • Analyzes emerging opportunities, alternative market penetration strategies, market entry barriers/risks, and strategic planning issues.
MethodologyThe report is based on a combination of primary and secondary information sources, including interviews with laboratory directors, and executives of leading diagnostics companies and start-up firms developing innovative products. In addition to primary sources of information, a comprehensive review of the most recent technical and business publications, manufacturer product and financial literature, as well as Venture Planning Group's proprietary data files was conducted.

Contains 322 pages and 20 tables
I. INTRODUCTION

II. WORLDWIDE MARKET AND TECHNOLOGY OVERVIEW

A. Major Infectious Disease Tests
  1. Campylobacter
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
  2. Cryptosporidium
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
  3. E. Coli
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
  4. Enteroviruses
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
  5. RhinoViruses
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
  6. RotaVirus (REOVIRUS)
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
  7. Salmonellosis
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
  8. Shigellosis
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
  9. Vibrio
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
  10. Yersinia
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
B. Instrumentation Review of Leading Analyzers Marketed by Abbott, Beckman Coulter/Danaher, BioMerieux, Ortho-Clinical Diagnostics, Roche, Siemens, Tosoh, Wallac and Other Suppliers
C. Emerging Diagnostic Technologies
  1. Molecular Diagnostics
  2. Monoclonal Antibodies
  3. Immunoassays
  4. Differential Light Scattering
  5. Information Technology
  6. Artificial Intelligence
  7. Liposomes
  8. Flow Cytometry
  9. Chromatography
  10. Diagnostic Imaging
  11. Gel Microdroplets
  12. Other

III. FRANCE: MARKET SIZE, GROWTH AND MAJOR SUPPLIERS’ SALES AND MARKET SHARES

ALTERNATIVE MARKET PENETRATION STRATEGIES

A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized Testing Markets
  1. Marketing Approaches
  2. Product Complexity
  3. Customer Preference
  4. Established Suppliers
  5. Emerging Suppliers
  6. Major Types of Distributors
  7. Market Segmentation

Potential Market Entry Barriers and Risks

A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges

COMPETITIVE ASSESSMENTS

Abbott
Affymetrix
Beckman Coulter/Danaher
Becton Dickinson
bioMerieux
Bio-Rad
Cepheid
Diamedix
DiaSorin
Eiken Chemical
Enzo Biochem
Fujirebio
Gen-Probe
Hologic
ID Biomedical
Innogenetics/Solvay
Kreatech
Life Technology
Lonza
Nanogen/Elitech
Novartis Diagnostics
Ortho-Clinical Diagnostics
Qiagen
Roche
Scienion
Sequenom
SeraCare
Siemens
Takara Bio
Thermo Fisher
Wallac
WakoFrance Enteric Diseases Global Market Outlook and Emerging Opportunities

LIST OF TABLES

Major Companies Developing or Marketing Campylobacter Tests
Major Companies Developing or Marketing Enterovirus Tests
Major Companies Developing or Marketing Rotavirus Tests
Major Companies Developing or Marketing Salmonella Tests
Major Companies Developing or Marketing Shigella Tests
Major Companies Developing or Marketing Yersinia Tests
France Campylobacter Test Volume and Diagnostics Sales Forecast by Market Segment
France Campylobacter Diagnostics Sales by Major Supplier
France Cryptosporidium Test Volume and Diagnostics Sales Forecast by Market Segment
France Cryptosporidium Diagnostics Sales by Major Supplier
France E. Coli Test Volume and Diagnostics Sales Forecast by Market Segment
France Enterovirus Test Volume and Diagnostics Sales Forecast by Market Segment
France Rhinovirus Test Volume and Diagnostics Sales Forecast by Market Segment
France Rotavirus Test Volume and Diagnostics Sales Forecast by Market Segment
France Rotavirus Testing Market Diagnostics Sales by Major Supplier
France Salmonella Test Volume and Diagnostics Sales Forecast by Market Segment
France Shigella Test Volume and Diagnostics Sales Forecast by Market Segment
France Shigella Testing Market Diagnostics Sales by Major Supplier
France Vibrio Test Volume and Diagnostics Sales Forecast by Market Segment
France Yersinia Test Volume and Diagnostics Sales Forecast by Market Segment
Skip to top


Ask Your Question

2014 Analysis of Enteric Diseases in France: Market Outlook and Emerging Opportunities
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: